Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Jen‐Shi Chen | Researchclopedia

Back to researchers

Jen‐Shi Chen

Chang Gung University ORCID

305

Works

24,142

Citations

44

h-index

192

i10-index

Research Topics

Palliative Care and End-of-Life Issues Gastric Cancer Management and Outcomes Pancreatic and Hepatic Oncology Research

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)2018–2018

Memorial Hospital of South Bend2003–2019

National Yang Ming Chiao Tung University2009–2009

National Taiwan Ocean University2007–2007

National Health Research Institutes2007–2015

Top Works

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

Éric Raymond,Laëtitia Dahan,et al.

20112,525 citations

Cholangiocarcinoma and Gallbladder Cancer Studies

Cancer survivorship and care

Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Yoon‐Koo Kang,Narikazu Boku,et al.

20172,248 citations

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam,Chung‐Pin Li,et al.

20151,175 citations

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

Sung Hoon Noh,Sook Ryun Park,et al.

20141,051 citations

Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer

Do‐Youn Oh,Aiwu Ruth He,et al.

20221,020 citations

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley,Makoto Ueno,et al.

2023943 citations

Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial

Yoon‐Koo Kang,Li‐Tzong Chen,et al.

2022731 citations

Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study

Hideki Ueno,Tatsuya Ioka,et al.

2013629 citations

A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data

Li‐Tzong Chen,Taroh Satoh,et al.

2019227 citations